SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings proposed stock and convertible-note offerings have become the main focus after positive VK2735 weight-loss maintenance data fueled a rally. Traders are divided over the dilution and whether the raise signals no near-term buyout, versus the added funding runway for development and commercialization strengthening Vikings position.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX shares are under pressure amid concerns about an upcoming lockup expiration adding to available share supply and COO Gwynne Shotwells disclosed planned stock sale. Bears see insider selling and the companys lofty valuation as reasons for caution, while bulls argue the sale was preplanned and are buying the dip.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds shares sold off after managements investor-day outlook pointed to persistent inflation and weak restaurant traffic, while its multiyear growth plan calls for substantial restaurant and franchisee investment. Traders debate whether the decline is an overreaction and a buying opportunity or a sign that high prices and softer consumer demand will continue to weigh on the business.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys first Alloy Kore design win with Daimler TruckVolvo venture Coretura is drawing attention alongside upcoming quarterly results. Traders see growth potential for QNX, while others are frustrated by the muted share-price response and want evidence that the backlog can convert into revenue.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Large, unusual October call activity is drawing attention to Unity, with traders debating whether the trades signal a bullish bet or reflect call sales and hedging. Buyout, Meta-event, and Roaring Kitty theories are circulating, but remain speculation rather than confirmed catalysts.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is drawing attention as an FDA advisory panel reviews Galleri, its multi-cancer blood-screening test, with trading halted during the proceedings. Traders are split between optimism about favorable FDA briefing materials and public testimony and concern that panel questions about accuracy and the early detection designation could limit Medicare coverage, even if the test wins support.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

FDA scrutiny and compliance concerns around Hims GLP-1 and compounded weight-loss offerings are weighing on sentiment, while traders cite Australia expansion and potential peptide offerings as growth offsets. The community is split between concerns about regulatory risk and frustration with repeated failed breakouts, and bullish views that new growth opportunities could eventually revive the stock.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos Capital Markets Day growth outlook and long-dated pipeline targets failed to reassure investors, amid concerns about pricing pressure, Eli Lillys competition and semaglutides future patent expiration. Traders criticized management and the selloff, while some argued the shares are undervalued and pointed to oral Wegovy demand as a potential offset.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Traders are circulating independent testing claims that Metas Muse agent routes a meaningful share of traffic through Fastly, particularly interactive browser tasks, fueling an AI-edge infrastructure re-rating narrative. Bulls see potential benefit from agentic AI and Fastlys edge and security offerings, while skeptics question whether the traffic data will translate into durable revenue and warn that the sharp rally may fade.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturuss OTC-deficiency Phase 2 update and pipeline announcement, including plans for ARCT-2601 with LUNAR 2.0 and its myNEO acquisition, are driving discussion. Traders see the data and delivery technology as encouraging, while others are concerned about shifted program timelines and the added spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
